EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,642
Closed -$253K 119
2023
Q3
$253K Sell
7,642
-9,256
-55% -$327K 0.33% 91
2023
Q2
$620K Sell
16,898
-566
-3% -$22K 0.81% 39
2023
Q1
$713K Buy
17,464
+175
+1% +$7.56K 0.97% 33
2022
Q4
$886K Sell
17,289
-102
-0.6% -$4.89K 1.3% 25
2022
Q3
$761K Buy
17,391
+2,424
+16% +$118K 1.31% 26
2022
Q2
$785K Buy
14,967
+1,102
+8% +$56.2K 1.21% 25
2022
Q1
$718K Sell
13,865
-506
-4% -$26.3K 0.93% 32
2021
Q4
$852K Buy
+14,371
New +$712K 1.12% 23

Other funds holding PFE

EAGLE HARBOR ASSET MANAGEMENT INC /ADV's PFE Position: Q4 2023 in Review

EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,642 shares — an estimated $253K sold.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $886K in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold 7,642 Pfizer shares in Q4 2023, an estimated $253K.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV's Pfizer position peaked at $886K in Q4 2022.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on EAGLE HARBOR ASSET MANAGEMENT INC /ADV's 13F filing for Q4 2023, filed 11 Aug 2026.